Nada Hamad

机构：St. Vincent's Birmingham, Sydney Hospital, UNSW Sydney, St Vincent's Hospital Melbourne, St Vincent's Hospital Sydney, Saint Vincent's Catholic Medical Center, The Catholic University of Korea St. Vincent's Hospital, St Vincent’s Private Hospital Sydney, St Vincent's Clinic, The Kinghorn Cancer Centre, The University of Notre Dame Australia · ORCID：0000-0001-7929-1450

发表论文 275 篇 · 总被引 3434 次 · h-index 25

代表论文

Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years (2024 · Nature Communications · 被引 25)
Ruxolitinib in Patients With Corticosteroid-Refractory or Corticosteroid-Dependent Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of the Phase III REACH3 Study (2025 · Journal of Clinical Oncology · 被引 18)
Comprehensive humoral and cellular immune responses to COVID-19 vaccination in adults with cancer (2024 · Vaccine · 被引 15)
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study (2025 · Journal of Clinical Oncology · 被引 14)
A Randomized Phase 2, Investigator-Led Trial of Glofitamab-R-CHOP or Glofitamab-Polatuzumab Vedotin-R-CHP (COALITION) in Younger Patients with High Burden, High-Risk Large B-Cell Lymphoma Demonstrates Safety, Uncompromised Chemotherapy Intensity, a High Rate of Durable Remissions, and Unique FDG-PET Response Characteristics (2024 · Blood · 被引 12)
Iron optimisation in pregnancy: a Haematology in Obstetric and Women's Health Collaborative consensus statement (2025 · Internal Medicine Journal · 被引 8)